Skip to main content

Table 3 Demographics and clinical information (N = 503)

From: Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat

Characteristic n (%)
Sex
 Male 215 (42.7)
 Female 288 (57.3)
Age
 40 to 50 years 108 (21.5)
 51 to 60 years 181 (36.0)
 61 to 70 years 159 (31.6)
 71 to 75 years 55 (10.9)
Race
 White 445 (88.5)
 Black/African American 33 (6.6)
 American Indian or Alaska Native 7 (1.4)
 Native Hawaiian 1 (0.2)
 Other Pacific Islander 0 (0.0)
 Asian 4 (0.8)
 Other 12 (2.4)
Highest grade completed
 Less than High School 74 (14.7)
 High School Diploma or equivalent (e.g., GED) 182 (36.2)
 Some College 119 (23.7)
 College Degree 82 (16.3)
 Professional or advanced degree 46 (9.1)
Employment status
 Employed full-time 114 (22.7)
 Employed part-time 28 (5.6)
 Not employed or retired 358 (71.2)
Number of Combivent Respimat prescriptions over past 8 months
 2 inhalers 143 (28.4)
 3 inhalers 100 (19.9)
 4 or more inhalers 260 (51.7)
Taking Combivent Respimat for:
 Chronic obstructive pulmonary disease only 236 (46.9)
 Asthma only 110 (21.9)
 Other lung disease only 41 (8.2)
 More than one disease 116 (23.1)
Using the Combivent Respimat for...
 Less than 3 months 68 (13.5)
 3 to 6 months 188 (37.4)
 7 to 12 months 179 (35.6)
 I don’t know 68 (13.5)
Take Combivent Respimat...
 Once daily 20 (4.0)
 Twice daily 120 (23.9)
 Other 95 (18.9)
 As needed 268 (53.3)
Ever used other inhalers?
 Yes 426 (84.7)
 No 77 (15.3)
Ever used nebulizer
 Yes 310 (61.6)
 No 157 (31.2)
 I don’t know 36 (7.2)